These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22903577)

  • 41. Introduction of non-natural amino acid residues into the substrate-specific P1 position of trypsin inhibitor SFTI-1 yields potent chymotrypsin and cathepsin G inhibitors.
    Łegowska A; Debowski D; Lesner A; Wysocka M; Rolka K
    Bioorg Med Chem; 2009 May; 17(9):3302-7. PubMed ID: 19362846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analogues of trypsin inhibitor SFTI-1 with disulfide bridge substituted by various length of carbonyl bridges.
    Legowska A; Bulak E; Jaśkiewicz A; Małuch I; Sieracki M; Wysocka M; Lesner A; Rolka K
    Protein Pept Lett; 2010 Oct; 17(10):1223-7. PubMed ID: 20518739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prospects for the design of new therapeutically significant protease inhibitors based on knottins and sunflower seed trypsin inhibitor (SFTI 1)].
    Kuznetsova SS; Kolesanova EF; Talanova AV; Veselovsky AV
    Biomed Khim; 2016 May; 62(4):353-68. PubMed ID: 27562989
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Scalable and Efficient In Planta Biosynthesis of Sunflower Trypsin Inhibitor-1 (SFTI) Peptide Therapeutics.
    Handley TNG; Jackson MA; Craik DJ
    Methods Mol Biol; 2022; 2371():117-142. PubMed ID: 34596846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and biological activity of seleno sunflower trypsin inhibitor analog.
    Guo X; Shi J; Tang Z; Cui D; Zhang Y
    Chem Biol Drug Des; 2006 Dec; 68(6):341-4. PubMed ID: 17177897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Addition of beta1-6 GlcNAc branching to the oligosaccharide attached to Asn 772 in the serine protease domain of matriptase plays a pivotal role in its stability and resistance against trypsin.
    Ihara S; Miyoshi E; Nakahara S; Sakiyama H; Ihara H; Akinaga A; Honke K; Dickson RB; Lin CY; Taniguchi N
    Glycobiology; 2004 Feb; 14(2):139-46. PubMed ID: 14551220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immobilization of sunflower trypsin inhibitor (SFTI-1) peptide onto a gold surface and analysis of its interaction with trypsin.
    Ohtsuka K; Kajiki R; Waki M; Nojima T; Takenaka S
    Analyst; 2004 Oct; 129(10):888-9. PubMed ID: 15457316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analogues of trypsin inhibitor SFTI-1 modified in the conserved P₁' position by synthetic or non-proteinogenic amino acids retain their inhibitory activity.
    Rafał Ł; Anna Ł; Magdalena W; Dawid D; Adam L; Krzysztof R
    J Pept Sci; 2011 Apr; 17(4):281-7. PubMed ID: 21294226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peptide splicing in a double-sequence analogue of trypsin inhibitor SFTI-1 substituted in the P₁ positions by peptoid monomers.
    Karna N; Dębowski D; Łęgowska A; Bąchor R; Szewczuk Z; Rolka K
    Biopolymers; 2015 May; 104(3):206-12. PubMed ID: 25904562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sunflower trypsin inhibitor-1.
    Korsinczky ML; Schirra HJ; Craik DJ
    Curr Protein Pept Sci; 2004 Oct; 5(5):351-64. PubMed ID: 15544530
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recruiting Zn2+ to mediate potent, specific inhibition of serine proteases.
    Katz BA; Luong C
    J Mol Biol; 1999 Sep; 292(3):669-84. PubMed ID: 10497030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma.
    Förbs D; Thiel S; Stella MC; Stürzebecher A; Schweinitz A; Steinmetzer T; Stürzebecher J; Uhland K
    Int J Oncol; 2005 Oct; 27(4):1061-70. PubMed ID: 16142324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two proteins for the price of one: Structural studies of the dual-destiny protein preproalbumin with sunflower trypsin inhibitor-1.
    Franke B; James AM; Mobli M; Colgrave ML; Mylne JS; Rosengren KJ
    J Biol Chem; 2017 Jul; 292(30):12398-12411. PubMed ID: 28536266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combinatorial optimization of cystine-knot peptides towards high-affinity inhibitors of human matriptase-1.
    Glotzbach B; Reinwarth M; Weber N; Fabritz S; Tomaszowski M; Fittler H; Christmann A; Avrutina O; Kolmar H
    PLoS One; 2013; 8(10):e76956. PubMed ID: 24146945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diarylethene-Based Photoswitchable Inhibitors of Serine Proteases.
    Babii O; Afonin S; Diel C; Huhn M; Dommermuth J; Schober T; Koniev S; Hrebonkin A; Nesterov-Mueller A; Komarov IV; Ulrich AS
    Angew Chem Int Ed Engl; 2021 Sep; 60(40):21789-21794. PubMed ID: 34268844
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Erythrina caffra trypsin inhibitor retains its native structure and function after reducing its disulfide bonds.
    Lehle K; Wrba A; Jaenicke R
    J Mol Biol; 1994 Jun; 239(2):276-84. PubMed ID: 8196058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mastering the canonical loop of serine protease inhibitors: enhancing potency by optimising the internal hydrogen bond network.
    Swedberg JE; de Veer SJ; Sit KC; Reboul CF; Buckle AM; Harris JM
    PLoS One; 2011 Apr; 6(4):e19302. PubMed ID: 21556330
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Introduction of Pro and its analogues in the conserved P1' position of trypsin inhibitor SFTI-1 retains its inhibitory activity.
    Łęgowska A; Dębowski D; Łukajtis R; Sztabkowska E; Mizeria A; Brzozowski K; Wysocka M; Lesner A; Rolka K
    Protein Pept Lett; 2011 Nov; 18(11):1158-67. PubMed ID: 21605056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Secondary amides of sulfonylated 3-amidinophenylalanine. New potent and selective inhibitors of matriptase.
    Steinmetzer T; Schweinitz A; Stürzebecher A; Dönnecke D; Uhland K; Schuster O; Steinmetzer P; Müller F; Friedrich R; Than ME; Bode W; Stürzebecher J
    J Med Chem; 2006 Jul; 49(14):4116-26. PubMed ID: 16821772
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The optimal activity of a pseudozymogen form of recombinant matriptase under the mildly acidic pH and low ionic strength conditions.
    Inouye K; Yasumoto M; Tsuzuki S; Mochida S; Fushiki T
    J Biochem; 2010 Apr; 147(4):485-92. PubMed ID: 19919953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.